[HTML][HTML] Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants

L Yang, P Chai, J Yu, X Fan - Cancer Biology & Medicine, 2021 - ncbi.nlm.nih.gov
Objective: Patients with underlying diseases are more vulnerable to coronavirus disease
2019 (COVID-19). The purpose of this study was to investigate cancer incidence in patients …

Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross …

J Hong, X Xu, J Yang, J Zheng, S Dai, J Zhou… - Journal of integrative …, 2022 - Elsevier
Objective The coronavirus disease 2019 (COVID-19) pandemic has had a serious impact on
health all over the world. Cancer patient, whose immunity is often compromised, faces a …

[HTML][HTML] Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective …

L Monin, AG Laing, M Muñoz-Ruiz… - The Lancet …, 2021 - thelancet.com
Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients
with cancer is unknown. We aimed to assess the safety and immunogenicity of the …

[HTML][HTML] Overview and countermeasures of cancer burden in China

Y Wang, Q Yan, C Fan, Y Mo, Y Wang, X Li… - Science China Life …, 2023 - Springer
Cancer is one of the leading causes of human death worldwide. Treatment of cancer
exhausts significant medical resources, and the morbidity and mortality caused by cancer is …

[HTML][HTML] Safety and tolerability of SARS-CoV2 emergency-use authorized vaccines for allogeneic hematopoietic stem cell transplant recipients

H Ali, D Ngo, A Aribi, S Arslan, S Dadwal… - … and cellular therapy, 2021 - Elsevier
The safety and efficacy of the severe acute respiratory syndrome coronavirus-2 (SARS-
CoV2) emergency-use authorized (EUA) vaccines have been confirmed in the general …

[HTML][HTML] Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options

MD Mohiuddin, K Kasahara - Respiratory Medicine, 2022 - Elsevier
The COVID-19 pandemic has put a strain on all the healthcare systems around the world.
The World Health Organization (WHO) stated that the “highly mutated” Omicron variant …

Antigen‐specific and cross‐reactive T cells in protection and disease

N Jiang, M Malone, S Chizari - Immunological reviews, 2023 - Wiley Online Library
Human T cells have a diverse T‐cell receptor (TCR) repertoire that endows them with the
ability to identify and defend against a broad spectrum of antigens. The universe of possible …

[HTML][HTML] Links between infections, lung cancer, and the immune system

L Budisan, O Zanoaga, C Braicu, R Pirlog… - International journal of …, 2021 - mdpi.com
Lung cancer is the leading disease of cancer-related deaths worldwide. Since the beginning
of the 20th century, various infectious agents associated with lung cancer have been …

SARS‐CoV‐2 infection and lytic reactivation of herpesviruses: A potential threat in the postpandemic era?

J Chen, J Song, L Dai, SR Post… - Journal of medical …, 2022 - Wiley Online Library
The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which
is the causative pathogen for the coronavirus disease 2019 (COVID‐19) pandemic, has …

[HTML][HTML] COVID-19 in cancer patients, risk factors for disease and adverse outcome, a population-based study from Norway

TB Johannesen, S Smeland, S Aaserud… - Frontiers in …, 2021 - frontiersin.org
Background Cancer has been suggested as a risk factor for severe outcome of SARS-CoV-2
infection. In this population-based study we aimed to identify factors associated with higher …